Navigation Links
Demand for Outpatient Diagnostic Imaging Forecast to Increase by Double Digits Across All Modalities Through 2012
Date:4/23/2009

Washington G-2 Reports releases top-10 trends to watch in the diagnostic imaging industry

NEWARK, N.J., April 23 /PRNewswire/ -- Demand for outpatient diagnostic imaging has never been higher; and it is only expected to increase over the next three years. In fact, demand for outpatient diagnostic imaging is expected to increase by double digits across all modalities (CT, nuclear Cardiology, MRI, ultrasound, general radiology, DEXA, PET, mammography, nuclear science) through 2012, with CT volume increasing by nearly 76.9% followed by nuclear cardiography (41.1%) and MRI (39.6%). Some of the factors influencing the top trend in diagnostic imaging include: new technology and growth in available applications, aging demographics, increased consumerism, the practice of preventative medicine by physicians, and expansion of coverage, particularly for PET scans.

Washington G-2 Reports' Diagnostic Imaging Industry Outlook 2009: Market Trends & Analysis provides expert perspective on the top 10 trends that will shape the structure and the growth of the diagnostic imaging industry, through 2012. The research provides insight into the size and structure of the U.S. diagnostic imaging market, managed care, Medicare and Medicaid, M&A, modality utilization and trends, the imaging equipment market and the overall outlook for the U.S. diagnostic and imaging market -- including advice on imminent challenges that could affect providers' ability to expand or even survive in coming years.

The research includes profiles of publicly traded U.S. diagnostic imaging chains, including: Alliance Imaging, HCA, Inc., InSight Health Services and RadNet, Inc. Each profile includes critical contact info (address, telephone, email, fax, names of leading employees (e.g., CEO, VPs, Directors)), a company overview, and financial information (e.g., revenue, pre-tax and net income, shareholder's equity).

Diagnostic Imaging Industry Outlook is an exclusive 104-page report supported by 60 tables and charts. For more details, call 302-645-2640, email kscott@ioma.com, or visit www.g2reports.com.

About Washington G-2 Reports

An independent news and information service, specializing in diagnostic testing and related medical services, Washington G-2 Reports is the leading market research and publishing firm serving the clinical diagnostic laboratory market in the U.S. Washington G-2 Reports offers timely, accurate reporting and analysis to subscribers in all 50 states, Puerto Rico, Canada, Europe and Asia. In addition to publishing a variety of newsletters, reference guides and research, Washington G-2 Reports sponsors the Lab Institute and other related programs. Washington G-2 Reports is a division of the Institute of Management and Administration (IOMA, Newark, N.J.), a subsidiary of the Bureau of National affairs (Washington, D.C.).


'/>"/>
SOURCE Washington G-2 Reports
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. PLUS Diagnostics Opens West Coast Laboratory to Support Increased Demand for Anatomic Pathology Services
2. Surgical education programs have demand for physician assistants and nurse practitioners
3. Millstone Medical Outsourcing Celebrates New Fall River Facility, Designed to Meet Demand for Advanced Inspection, Clean Room Services
4. Deloitte Survey Finds Healthy Consumer Demand For Electronic Health Records, Online Tools and Services
5. Rise in Sleeping Disorders Triggers High Demand for Sleep Service Facilities in Europe, Notes Frost & Sullivan
6. InfoLogix Partners with TeleHealth Services to Enable On-Demand Healthcare Infrastructure for Hospitals Across the U.S.
7. TeleHealth Services Announces TIGR On-Demand Video Patient Education Version 7 Unveiling at HIMSS 2009
8. Chemed Corporation Purchases a Second Corporate Jet - MMI Investments Demands an End to Chemed Corporate Largesse
9. For Diabetics, On-Demand Care May Not Help
10. Cepheid Announces European Release of First On-Demand Molecular Pre-Surgical Screening Test for Simultaneous Detection of Methicillin-Sensitive and Resistant S. aureus
11. Epson Introduces Color On Demand Inkjet Printer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... ... newest advanced absorption cannabidiol (CBD) serum, “NANOCALM 300” Microemulsified Hemp Extract. This ... instant absorption from the mouth into the bloodstream. Far outpacing the ...
(Date:2/22/2017)... ... 22, 2017 , ... The Centers for Medicare & Medicaid ... in Delaware, New Jersey, Pennsylvania and West Virginia prepare for and participate in ... Act of 2015 (MACRA). , This technical assistance, authorized and funded under ...
(Date:2/22/2017)... NJ (PRWEB) , ... February 22, 2017 , ... ... healthcare communications company, launched a new media platform connecting healthcare technology professionals and ... will be followed by a quarterly publication starting on March 1, announced Michael ...
(Date:2/22/2017)... ... February 22, 2017 , ... Pet obesity in the U.S. continued ... according to the Association for Pet Obesity Prevention (APOP). During the ninth annual survey, ... such as the benefits of corn and grains, value of raw and organic diets, ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... so many different solutions on the market, it is easy to start feeling ... Premier Locksmith offers a complimentary security consultation. , Home Security Hardware Choices, ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... , Feb. 22, 2017 Henry ... an exclusive distribution agreement with Rijuven, which develops ... diagnostic device to medical practitioners. ... electrocardiogram (ECG) and heart sound signals, transmits real-time ... and offers cloud-based analysis to help physicians provide ...
(Date:2/22/2017)... Calif. , Feb. 22, 2017  Bioness, Inc., ... therapies, today announced the first series of successful StimRouter ... at Radboud University Medical Center (Nijmegen, Netherlands ... ( Cork, Ireland ), and Kliniek Park ... the successful launch continuing, Bioness plans to further support ...
(Date:2/22/2017)... , Feb. 22, 2017 Oncternal Therapeutics, ... for both rare and common malignancies, today announced ... financing. The company intends to use the proceeds ... TK216, and to advance preclinical development of a ... Cirmtuzumab is a first-in-class anti-ROR1 monoclonal antibody being ...
Breaking Medicine Technology: